# Biotech Daily Digest â€” 2026-01-06

**50 items from 3 sources**

## Summary by Source

- Endpoints News: 10 items
- Fierce Biotech: 7 items
- arXiv q-bio: 33 items


## Endpoints News

- **[Lilly goes back to Nimbus for an oral obesity drug in $55M deal](https://endpoints.news/lilly-goes-back-to-nimbus-for-an-oral-obesity-drug-in-55m-deal/)**  
  _Tue, 06 Jan 2026 13:00:47 +0000_  
  Nimbus Therapeutics ended 2025 on a high note with a Phase 3 success for its Takeda-acquired immunology drug. The biotech is now continuing that good fortune in the new year through a ...

- **[Arrowheadâ€™s RNAi obesity programs head to Phase 2 after encouraging early data](https://endpoints.news/arrowheads-rnai-obesity-programs-head-to-phase-2-after-encouraging-early-data/)**  
  _Tue, 06 Jan 2026 12:30:29 +0000_  
  Arrowhead Pharmaceuticalsâ€™ gene-silencing obesity therapies have shown early signs of efficacy in a handful of patients, according to interim data.

 The company said Tuesday that one of its candidates, an RNAi-based product dubbed ARO-INHBE, improved ...

- **[Cartography does another pharma deal, this time with Pfizer](https://endpoints.news/cartography-does-another-pharma-deal-this-time-with-pfizer/)**  
  _Tue, 06 Jan 2026 12:30:19 +0000_  
  Cancer drug developer Cartography Biosciences has struck a deal with Pfizer that could be worth more than $850 million, if all goes well.

 The South San Francisco biotech will get as much as $65 million ...

- **[Appeals court rules against NIHâ€™s indirect cost cut plan](https://endpoints.news/appeals-court-rules-against-nihs-indirect-cost-cut-plan/)**  
  _Mon, 05 Jan 2026 23:54:56 +0000_  
  The government is barred from setting a 15% cap on overhead research cost reimbursements for NIH grantees under a federal appeals court order.

 The plain text of each appropriations law enacted since 2018 prohibits NIH ...

- **[FDA raises new questions with Sanofi's MS drug in release of rejection letter](https://endpoints.news/fda-raises-new-questions-with-sanofis-ms-drug-in-release-of-rejection-letter/)**  
  _Mon, 05 Jan 2026 20:22:17 +0000_  
  The FDA offered new details on why it rejected Sanofi's potential new multiple sclerosis drug late last year â€” a peek behind the veil that goes beyond what Sanofi said in public statements at the time ...

- **[HHS urges Supreme Court to decline AstraZeneca's petition over Medicare price negotiations](https://endpoints.news/hhs-urges-supreme-court-to-decline-astrazenecas-petition-over-medicare-price-negotiations/)**  
  _Mon, 05 Jan 2026 19:42:19 +0000_  
  The government has urged the US Supreme Court not to wade into its battle with drugmakers over Medicare negotiations â€” at least for now.

 Attorneys for HHS said on Friday that a ...

- **[US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups](https://endpoints.news/us-to-stop-recommending-six-vaccines-for-all-kids-prioritizing-individual-choice-and-higher-risk-groups/)**  
  _Mon, 05 Jan 2026 19:02:32 +0000_  
  The US will no longer recommend about a half-dozen vaccines for all kids, in a massive and swift overhaul of the childhood vaccination schedule.

 Senior federal health officials told reporters on a call Monday that ...

- **[Zenas BioPharmaâ€™s Phase 3 autoimmune disease readout disappoints](https://endpoints.news/zenas-biopharmas-phase-3-autoimmune-disease-readout-disappoints/)**  
  _Mon, 05 Jan 2026 16:21:59 +0000_  
  Zenas BioPharma said its experimental antibody succeeded in a pivotal study for IgG4-related disease, an autoimmune condition, and that it plans to seek FDA approval. But the topline findings compare poorly to an on-the-market rival ...

- **[Moderna seeks flu vaccine approvals; Neumora Alzheimer's data](https://endpoints.news/moderna-seeks-flu-vaccine-approvals-neumora-alzheimers-data/)**  
  _Mon, 05 Jan 2026 16:08:37 +0000_  
  Plus, news about Incyte's Monjuvi:

 ðŸ˜· Moderna submits flu vaccine to global regulators: The company said Monday it filed approval applications to regulators in the US, Europe ...

- **[Argenx to elevate Massey to CEO as it expands rare disease business](https://endpoints.news/argenx-to-elevate-massey-to-ceo-as-it-expands-rare-disease-business/)**  
  _Mon, 05 Jan 2026 15:30:16 +0000_  
  Rare disease drugmaker argenx will soon have a new CEO.

 COO Karen Massey will take over for current chief Tim Van Hauwermeiren in May, argenx announced Monday, as the company prepares for its next slate ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/alumis-beams-pivotal-data-sotyktu-rival-drive-stock-surge" hreflang="en">Alumis beams as pivotal data on Sotyktu rival drive stock surge</a>](https://www.fiercebiotech.com/biotech/alumis-beams-pivotal-data-sotyktu-rival-drive-stock-surge)**  
  _Jan 6, 2026 8:13am_  
  A pair of phase 3 psoriasis studies of Alumisâ€™ TYK2 inhibitor have hit their primary endpoints, setting the biotech up to file for approval of a potential challenger to Bristol Myers Squibbâ€™s Sotyktu. With the news, Alumisâ€™ shares more than doubled in premarket trading.

- **[<a href="https://www.fiercebiotech.com/biotech/instils-stock-sinks-after-clearing-out-clinical-pipeline-handing-2-drugs-back-immuneonco" hreflang="en">Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco</a>](https://www.fiercebiotech.com/biotech/instils-stock-sinks-after-clearing-out-clinical-pipeline-handing-2-drugs-back-immuneonco)**  
  _Jan 6, 2026 8:00am_  
  Instil Bioâ€™s hopes for its refreshed clinical pipeline appear to have ended in failure, with the U.S. biotech handing the rights to two drugs back to their original owner.

- **[<a href="https://www.fiercebiotech.com/biotech/pfizer-charts-course-tumor-selective-antigens-865m-cartography-collab" hreflang="en">Pfizer charts course to tumor-selective antigens in $865M Cartography collab</a>](https://www.fiercebiotech.com/biotech/pfizer-charts-course-tumor-selective-antigens-865m-cartography-collab)**  
  _Jan 5, 2026 2:17pm_  
  Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks.

- **[<a href="https://www.fiercebiotech.com/biotech/gilead-garners-lipid-package-cancer-asset-300m-research-pact" hreflang="en">Gilead garners lipid package for cancer asset in $300M research pact</a>](https://www.fiercebiotech.com/biotech/gilead-garners-lipid-package-cancer-asset-300m-research-pact)**  
  _Jan 5, 2026 2:00pm_  
  Gilead Sciences has found a shiny new package for one of its cancer assets, inking an up to $300 million research pact for access to OncoNano Medicineâ€™s tumor-targeting lipid particles.

- **[<a href="https://www.fiercebiotech.com/biotech/fda-cites-severe-liver-injury-risk-unclear-benefit-behind-sanofis-ms-drug-rejection" hreflang="en">FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection</a>](https://www.fiercebiotech.com/biotech/fda-cites-severe-liver-injury-risk-unclear-benefit-behind-sanofis-ms-drug-rejection)**  
  _Jan 5, 2026 5:17pm_  
  Less than two weeks after rejecting Sanofiâ€™s investigational multiple sclerosis drug, the FDA has publicly shared the complete response letter, citing both efficacy and safety concerns, including a case of serious liver injury that led to death.

- **[<a href="https://www.fiercebiotech.com/biotech/metavia-weighs-9-loss-dual-agonist-enters-obesity-ring" hreflang="en">MetaVia weighs in with 9% loss as dual agonist enters the obesity ring</a>](https://www.fiercebiotech.com/biotech/metavia-weighs-9-loss-dual-agonist-enters-obesity-ring)**  
  _Jan 5, 2026 9:50am_  
  MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who received its dual agonist of GLP-1 and glucagon in a phase 1 trial.

- **[<a href="https://www.fiercebiotech.com/biotech/zenas-indigo-data-leaves-wall-street-feeling-blue-despite-primary-endpoint-hit" hreflang="en">Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit</a>](https://www.fiercebiotech.com/biotech/zenas-indigo-data-leaves-wall-street-feeling-blue-despite-primary-endpoint-hit)**  
  _Jan 5, 2026 8:53am_  
  With the result falling short of the bar Amgen set in another study, investors sent Zenasâ€™ share price down 48% to $18 in premarket trading.


## arXiv q-bio

- **[Deep Learning Framework for RNA Inverse Folding with Geometric Structure Potentials](https://arxiv.org/abs/2601.00895)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.00895v1 Announce Type: new 
Abstract: RNA's diverse biological functions stem from its structural versatility, yet accurately predicting and designing RNA sequences given a 3D conformation (inverse folding) remains a challenge. Here, I introduce a deep learning framework that integrates Geometric Vector Perâ€¦

- **[Comparative Analysis of Formula and Structure Prediction from Tandem Mass Spectra](https://arxiv.org/abs/2601.00941)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.00941v1 Announce Type: new 
Abstract: Liquid chromatography mass spectrometry (LC-MS)-based metabolomics and exposomics aim to measure detectable small molecules in biological samples. The results facilitate hypothesis-generating discovery of metabolic changes and disease mechanisms and provide informationâ€¦

- **[A Biologically Plausible Dense Associative Memory with Exponential Capacity](https://arxiv.org/abs/2601.00984)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.00984v1 Announce Type: new 
Abstract: Krotov and Hopfield (2021) proposed a biologically plausible two-layer associative memory network with memory storage capacity exponential in the number of visible neurons. However, the capacity was only linear in the number of hidden neurons. This limitation arose fromâ€¦

- **[Quantifying Local Strain Field and Deformation in Active Contraction of Bladder Using a Pretrained Transformer Model: A Speckle-Free Approach](https://arxiv.org/abs/2601.01315)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01315v1 Announce Type: new 
Abstract: Accurate quantification of local strain fields during bladder contraction is essential for understanding the biomechanics of bladder micturition, in both health and disease. Conventional digital image correlation (DIC) methods have been successfully applied to various bâ€¦

- **[HyperNetWalk: A Unified Framework for Personalized and Population-Level Cancer Driver Gene Identification via Multi-Network Hypergraph Diffusion](https://arxiv.org/abs/2601.01337)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01337v1 Announce Type: new 
Abstract: Identifying cancer driver genes is crucial for understanding tumor biology and developing precision therapies. However, existing computational methods often rely on single biological networks or population-level mutation patterns, limiting their ability to identify patiâ€¦

- **[A New Framework for Explainable Rare Cell Identification in Single-Cell Transcriptomics Data](https://arxiv.org/abs/2601.01358)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01358v1 Announce Type: new 
Abstract: The detection of rare cell types in single-cell transcriptomics data is crucial for elucidating disease pathogenesis and tissue development dynamics. However, a critical gap that persists in current methods is their inability to provide an explanation based on genes forâ€¦

- **[Dependence Structure and Epidemic Outcomes in Heterogeneous SIR Models](https://arxiv.org/abs/2601.01549)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01549v1 Announce Type: new 
Abstract: We study a well mixed SIR epidemic model with heterogeneous susceptibility and infectivity, allowing for an arbitrary joint distribution of these traits. Using an exact final size formulation and a branching process approximation for early epidemic dynamics, we show thaâ€¦

- **[From Theory of Mind to Theory of Environment: Counterfactual Simulation of Latent Environmental Dynamics](https://arxiv.org/abs/2601.01599)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01599v1 Announce Type: new 
Abstract: The vertebrate motor system employs dimensionality-reducing strategies to limit the complexity of movement coordination, for efficient motor control. But when environments are dense with hidden action-outcome contingencies, movement complexity can promote behavioral innâ€¦

- **[Fold-switching proteins push the boundaries of conformational ensemble prediction](https://arxiv.org/abs/2601.01740)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01740v1 Announce Type: new 
Abstract: A protein's function depends critically on its conformational ensemble, a collection of energy weighted structures whose balance depends on temperature and environment. Though recent deep learning (DL) methods have substantially advanced predictions of single protein stâ€¦

- **[Insular intracranial activity identifies multiple facial expressions via diverse, intermixed temporal patterns at the single-contact level](https://arxiv.org/abs/2601.01782)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01782v1 Announce Type: new 
Abstract: How neural representations in the insular cortex support emotional processing remains poorly understood, and the extent to which the insula is specialized for disgust processing remains debated. We recorded stereoelectroencephalography data from the insula while human sâ€¦

- **[Allostery Beyond Amplification: Temporal Regulation of Signaling Information](https://arxiv.org/abs/2601.01850)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01850v1 Announce Type: new 
Abstract: Allostery is a fundamental mechanism of protein regulation and is commonly interpreted as modulating enzymatic activity or product abundance. Here we show that this view is incomplete. Using a stochastic model of allosteric regulation combined with an information-theoreâ€¦

- **[A neural network for modeling human concept formation, understanding and communication](https://arxiv.org/abs/2601.02010)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02010v1 Announce Type: new 
Abstract: A remarkable capability of the human brain is to form more abstract conceptual representations from sensorimotor experiences and flexibly apply them independent of direct sensory inputs. However, the computational mechanism underlying this ability remains poorly understâ€¦

- **[How much neuroscience does a neuroscientist need to know?](https://arxiv.org/abs/2601.02063)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02063v1 Announce Type: new 
Abstract: How much of the brain's learned algorithms depend on the fact it is a brain? We argue: a lot, but surprisingly few details matter. We point to simple biological details -- e.g. nonnegative firing and energetic/space budgets in connectionist architectures -- which, whenâ€¦

- **[Responses of the Neurobiological Craving Signature to smoking versus alternative social rewards predict craving and monthly smoking in adolescents](https://arxiv.org/abs/2601.02143)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02143v1 Announce Type: new 
Abstract: Smoking remains the leading cause of preventable mortality worldwide. Adolescents are particularly vulnerable to the development of tobacco addiction due to ongoing brain maturation and susceptibility to social influences, such as exposure to environmental tobacco smokeâ€¦

- **[Predicting Early and Complete Drug Release from Long-Acting Injectables Using Explainable Machine Learning](https://arxiv.org/abs/2601.02265)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02265v1 Announce Type: new 
Abstract: Polymer-based long-acting injectables (LAIs) have transformed the treatment of chronic diseases by enabling controlled drug delivery, thus reducing dosing frequency and extending therapeutic duration. Achieving controlled drug release from LAIs requires extensive optimiâ€¦

- **[Mapping the landscape of mathematical models for antimicrobial resistance: a scoping review](https://arxiv.org/abs/2601.02308)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02308v1 Announce Type: new 
Abstract: Background: Antimicrobial resistance (AMR) is a major global public health problem, contributing to an estimated 4.95 million deaths in 2019 and projected to cause up to 10 million deaths annually and 100 trillion dollars in cumulative economic losses by 2050. Its emergâ€¦

- **[Selective Imperfection as a Generative Framework for Analysis, Creativity and Discovery](https://arxiv.org/abs/2601.00863)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.00863v1 Announce Type: cross 
Abstract: We introduce materiomusic as a generative framework linking the hierarchical structures of matter with the compositional logic of music. Across proteins, spider webs and flame dynamics, vibrational and architectural principles recur as tonal hierarchies, harmonic progâ€¦

- **[Central Dogma Transformer: Towards Mechanism-Oriented AI for Cellular Understanding](https://arxiv.org/abs/2601.01089)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01089v1 Announce Type: cross 
Abstract: Understanding cellular mechanisms requires integrating information across DNA, RNA, and protein - the three molecular systems linked by the Central Dogma of molecular biology. While domain-specific foundation models have achieved success for each modality individuallyâ€¦

- **[Beyond P-Values: Importing Quantitative Finance's Risk and Regret Metrics for AI in Learning Health Systems](https://arxiv.org/abs/2601.01116)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01116v1 Announce Type: cross 
Abstract: The increasing deployment of artificial intelligence (AI) in clinical settings challenges foundational assumptions underlying traditional frameworks of medical evidence. Classical statistical approaches, centered on randomized controlled trials, frequentist hypothesisâ€¦

- **[Unveiling the Heart-Brain Connection: An Analysis of ECG in Cognitive Performance](https://arxiv.org/abs/2601.01424)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01424v1 Announce Type: cross 
Abstract: Understanding the interaction of neural and cardiac systems during cognitive activity is critical to advancing physiological computing. Although EEG has been the gold standard for assessing mental workload, its limited portability restricts its real-world use. Widelyâ€¦

- **[An AI-guided mechanotyping instrument for fully automated oocyte quality assessment](https://arxiv.org/abs/2601.01728)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01728v1 Announce Type: cross 
Abstract: The mechanical properties of oocytes are regarded as important indicators of their developmental potential. During fertilization, deviations from the normal mechanical range can hinder sperm penetration, ultimately reducing fertilization efficiency and compromising emâ€¦

- **[Toward Auditable Neuro-Symbolic Reasoning in Pathology: SQL as an Explicit Trace of Evidence](https://arxiv.org/abs/2601.01875)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01875v1 Announce Type: cross 
Abstract: Automated pathology image analysis is central to clinical diagnosis, but clinicians still ask which slide features drive a model's decision and why. Vision-language models can produce natural language explanations, but these are often correlational and lack verifiableâ€¦

- **[Oscillatory evolutionarily stable state and limit cycle in replicator dynamics](https://arxiv.org/abs/2601.01996)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.01996v1 Announce Type: cross 
Abstract: The idea of evolutionarily stable state (ESS) of a population is a cornerstone of evolutionary game theory; moreover, it coincides with the game-theoretic concept of Nash equilibrium. Such a state corresponds to a strategy adopted by the population such that a rare muâ€¦

- **[Edge-aware GAT-based protein binding site prediction](https://arxiv.org/abs/2601.02138)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2601.02138v1 Announce Type: cross 
Abstract: Accurate identification of protein binding sites is crucial for understanding biomolecular interaction mechanisms and for the rational design of drug targets. Traditional predictive methods often struggle to balance prediction accuracy with computational efficiency whâ€¦

- **[ETDock: A Novel Equivariant Transformer for Protein-Ligand Docking](https://arxiv.org/abs/2310.08061)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2310.08061v2 Announce Type: replace 
Abstract: Predicting the docking between proteins and ligands is a crucial and challenging task for drug discovery. However, traditional docking methods mainly rely on scoring functions, and deep learning-based docking approaches usually neglect the 3D spatial information ofâ€¦

- **[From In Silico to In Vitro: A Comprehensive Guide to Validating Bioinformatics Findings](https://arxiv.org/abs/2502.03478)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2502.03478v2 Announce Type: replace 
Abstract: The integration of bioinformatics predictions and experimental validation plays a pivotal role in advancing biological research, from understanding molecular mechanisms to developing therapeutic strategies. Bioinformatics tools and methods offer powerful means for pâ€¦

- **[Diagrammatic expressions for steady-state distribution and static responses in population dynamics](https://arxiv.org/abs/2505.11296)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2505.11296v3 Announce Type: replace 
Abstract: One of the fundamental questions in population dynamics is how biological populations respond to environmental perturbations. In population dynamics, the mean fitness and the fraction of a trait in the steady state are important because they indicate how well the trâ€¦

- **[The Bayesian Origin of the Probability Weighting Function in Human Representation of Probabilities](https://arxiv.org/abs/2510.04698)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2510.04698v2 Announce Type: replace 
Abstract: Understanding the representation of probability in the human mind has been of great interest to understanding human decision making. Classical paradoxes in decision making suggest that human perception distorts probability magnitudes. Previous accounts postulate a Pâ€¦

- **[Quantifying task-relevant representational similarity using decision variable correlation](https://arxiv.org/abs/2506.02164)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2506.02164v2 Announce Type: replace-cross 
Abstract: Previous studies have compared neural activities in the visual cortex to representations in deep neural networks trained on image classification. Interestingly, while some suggest that their representations are highly similar, others argued the opposite. Here,â€¦

- **[Contrastive Self-Supervised Learning As Neural Manifold Packing](https://arxiv.org/abs/2506.13717)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2506.13717v2 Announce Type: replace-cross 
Abstract: Contrastive self-supervised learning based on point-wise comparisons has been widely studied for vision tasks. In the visual cortex of the brain, neuronal responses to distinct stimulus classes are organized into geometric structures known as neural manifolds.â€¦

- **[Toward Efficient Spiking Transformers: Synapse Pruning Meets Synergistic Learning-Based Compensation](https://arxiv.org/abs/2508.01992)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2508.01992v4 Announce Type: replace-cross 
Abstract: As a foundational architecture of artificial intelligence models, Transformer has been recently adapted to spiking neural networks with promising performance across various tasks. However, existing spiking Transformer(ST)-based models require a substantial numâ€¦

- **[Modelling the emergence of open-ended cultural evolution](https://arxiv.org/abs/2508.04828)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2508.04828v2 Announce Type: replace-cross 
Abstract: Humans stand alone in terms of their potential to collectively and cumulatively change their culture in an open-ended manner. This open-endedness provides societies with the ability to continually expand their resources and to increase their capacity to store,â€¦

- **[Diagnosing Heteroskedasticity and Resolving Multicollinearity Paradoxes in Physicochemical Property Prediction](https://arxiv.org/abs/2512.24643)**  
  _Tue, 06 Jan 2026 00:00:00 -0500_  
  arXiv:2512.24643v2 Announce Type: replace-cross 
Abstract: Lipophilicity (logP) prediction remains central to drug discovery, yet linear regression models for this task frequently violate statistical assumptions in ways that invalidate their reported performance metrics. We analyzed 426,850 bioactive molecules from aâ€¦
